Veterinary Medicine Information website

Prinovox 40 mg + 10 mg spot-on solution for small dogs

Authorised
  • Moxidectin
  • Imidacloprid

Product identification

Medicine name:
Prinovox 40 mg + 10 mg spot-on solution for small dogs
Active substance:
  • Moxidectin
  • Imidacloprid
Target species:
  • Dog
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Moxidectin
    10.00
    milligram(s)
    /
    0.40
    millilitre(s)
  • Imidacloprid
    40.00
    milligram(s)
    /
    0.40
    millilitre(s)
Pharmaceutical form:
  • Spot-on solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AB52
Authorisation status:
  • Valid
Authorised in:
  • Portugal
Package description:
  • (ID6) 8.4 millilitre(s): unspecified outer container with 21 Pipette (polypropylene) each with 0.4 millilitre(s)
  • (ID5) 2.4 millilitre(s): unspecified outer container with 6 Pipette (polypropylene) each with 0.4 millilitre(s)
  • (ID4) 1.6 millilitre(s): unspecified outer container with 4 Pipette (polypropylene) each with 0.4 millilitre(s)
  • (ID3) 1.2 millilitre(s): unspecified outer container with 3 Pipette (polypropylene) each with 0.4 millilitre(s)
  • (ID2) 0.8 millilitre(s): unspecified outer container with 2 Pipette (polypropylene) each with 0.4 millilitre(s)
  • (ID1) 0.4 millilitre(s): unspecified outer container with 1 Pipette (polypropylene) with 0.4 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Elanco Animal Health GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • KVP Pharma+Veterinaer Produkte GmbH
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 1091/03/17RFVPT
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0196/003
Concerned member states:
  • Ireland
  • Italy
  • Portugal
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Portuguese (PDF)
Published on: 22/07/2025